Rowinsky Eric K
SEC-identified person · CIK 1318886 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Biogen INC. BIIB | Director | filed 2010 - 2026 |
| Verastem, Inc. VSTM | Director | filed 2017 - 2026 |
| Fortress Biotech, Inc. [CNDO] | Director · Vice Chairman of the Board | filed 2011 - 2024 |
| Neoprobe Corp NEOP | Director | filed 2010 - 2018 |
| Dnib Unwind, INC. BIND | Director | filed 2014 - 2016 |
| Stemline Therapeutics INC STML | EVP, Chief Med. Off., Head R&D | filed 2013 - 2015 |
| Savara Inc [ANX] | Director | filed 2008 - 2010 |
| Imclone Systems INC/DE IMCL | SVP, Chief Medical Officer | filed 2006 - 2008 |
| Tapestry Pharmaceuticals, INC TPPH | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.